The Trump administration's "Manhattan project" for a COVID-19 vaccine has topped its biggest award given only two weeks ago to Novavax, Inc with its latest grant of $2.1 billion to pharmaceutical giant, GlaxoSmithKline, and partner Sanofi Pasteur to "speed up clinical development and manufacturing" of its recombinant vaccine candidate for the novel
Grandes farmacéuticos gigantes GlaxoSmithKline, Sanofi reciben $ 2.1 mil millones para desarrollar la vacuna COVID
La Operación Warp Speed está entregando efectivo a una velocidad récord y esta vez, las dos compañías de vacunas más grandes del mundo se están beneficiando.